Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014)
Silvia Rivara, Daniele Pala, Annalida Bedini, et al.
Expert Opinion on Therapeutic Patents (2015) Vol. 25, Iss. 4, pp. 425-441
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Melatonin as a Hormone: New Physiological and Clinical Insights
José Cipolla‐Neto, Fernanda Gaspar do Amaral
Endocrine Reviews (2018) Vol. 39, Iss. 6, pp. 990-1028
Open Access | Times Cited: 535
Systems Chronotherapeutics
Annabelle Ballesta, Pasquale F. Innominato, Robert Dallmann, et al.
Pharmacological Reviews (2017) Vol. 69, Iss. 2, pp. 161-199
Open Access | Times Cited: 273
Quinone reductase 2 as a promising target of melatonin therapeutic actions
Jean A. Boutin
Expert Opinion on Therapeutic Targets (2015) Vol. 20, Iss. 3, pp. 303-317
Closed Access | Times Cited: 99
MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations
Paul Klosen, Sarawut Lapmanee, Carole Schuster, et al.
Journal of Pineal Research (2019) Vol. 67, Iss. 1
Open Access | Times Cited: 88
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder
Sébastien Lalanne, Claire Fougerou‐Leurent, George M. Anderson, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1490-1490
Open Access | Times Cited: 66
Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
Josiel Mileno Mack, Marissa Giovanna Schamne, Tuane Bazanella Sampaio, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 74
The role and therapeutic potential of melatonin in age‐related ocular diseases
Almudena Crooke, Fernando Huete‐Toral, Basilio Colligris, et al.
Journal of Pineal Research (2017) Vol. 63, Iss. 2
Open Access | Times Cited: 68
Redirecting drug repositioning to discover innovative cosmeceuticals
Georgia Sotiropoulou, Eleni Zingkou, Georgios Pampalakis
Experimental Dermatology (2021) Vol. 30, Iss. 5, pp. 628-644
Open Access | Times Cited: 43
A review of the protective effect of melatonin in pesticide-induced toxicity
Mohammad Hossein Asghari, Milad Moloudizargari, Haji Bahadar, et al.
Expert Opinion on Drug Metabolism & Toxicology (2016) Vol. 13, Iss. 5, pp. 545-554
Closed Access | Times Cited: 59
Melatonin reduces endoplasmic reticulum stress and autophagy in liver of leptin‐deficient mice
Beatriz de Luxán‐Delgado, Yaiza Potes, Adrian Rubio‐González, et al.
Journal of Pineal Research (2016) Vol. 61, Iss. 1, pp. 108-123
Closed Access | Times Cited: 57
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
G. Gatti, Valeria Lucini, S. Dugnani, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 68338-68353
Open Access | Times Cited: 54
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
Gilberto Spadoni, Annalida Bedini, Simone Lucarini, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 18, pp. 7512-7525
Open Access | Times Cited: 52
Effects of melatonin and its analogues on neural stem cells
Jiaqi Chu, Yalin Tu, Jingkao Chen, et al.
Molecular and Cellular Endocrinology (2015) Vol. 420, pp. 169-179
Closed Access | Times Cited: 49
Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus
Paul Pévet
Expert Opinion on Therapeutic Targets (2016) Vol. 20, Iss. 10, pp. 1209-1218
Closed Access | Times Cited: 44
Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy
Sebastian C. Holst, Amandine Valomon, Hans‐Peter Landolt
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 577-603
Open Access | Times Cited: 42
The role of melatonin in Multiple Sclerosis
Charalampos Skarlis, Maria Anagnostouli
Neurological Sciences (2019) Vol. 41, Iss. 4, pp. 769-781
Closed Access | Times Cited: 40
Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation
Xiaohong Fan, Junfang Li, Xuemei Deng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112217-112217
Closed Access | Times Cited: 38
Melatonin and the circadian system: Keys for health with a focus on sleep
Paul Pévet, Étienne Challet, Marie‐Paule Felder‐Schmittbuhl
Handbook of clinical neurology (2021), pp. 331-343
Closed Access | Times Cited: 28
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
Ahmed Elkamhawy, Jiyu Woo, Noha Gouda, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1604-1604
Open Access | Times Cited: 27
Hormonal disorders in autism spectrum disorders
Solmaz Jalilzadeh Khalet Abad, Galavizh Kalashipour Chir, Parivash Heydari, et al.
Hormone Molecular Biology and Clinical Investigation (2025)
Closed Access
Composition of food supplements containing melatonin available in Portugal
Bruno Vinicios Silva de Araújo, Fátima Rato, João Paulo Capela
Brazilian Journal of Pharmaceutical Sciences (2025) Vol. 61
Open Access
Melatonin's protective effect on the salivary gland against ionized radiation damage in rats
Isil Karaer, Gökçe Şimşek, Azibe Yıldız, et al.
Journal of Oral Pathology and Medicine (2016) Vol. 45, Iss. 6, pp. 444-449
Closed Access | Times Cited: 33
Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin
Silvia Bartolucci, Michele Mari, Giovanni Di Gregorio, et al.
Tetrahedron (2016) Vol. 72, Iss. 18, pp. 2233-2238
Open Access | Times Cited: 32
Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights
Zohaib Raza, Zainab Naureen
Nefrología (2019) Vol. 40, Iss. 1, pp. 12-25
Open Access | Times Cited: 30
Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors
Céline Legros, Clémence Dupré, Chantal Brasseur, et al.
Pharmacology Research & Perspectives (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top